INKT · Forms 3, 4, 5
Insider trades at MiNK Therapeutics, Inc.
1 insider sold $73K of MiNK Therapeutics, Inc. stock on the open market in the last 30 days.
Every Form 3, 4 and 5 filed for MiNK Therapeutics, Inc. (INKT) with the SEC, newest first: who traded, their role, buy or sell, shares, price and value.
Insider trades in the last 90 days
| Date | Insider | Role | Transaction | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Jennifer Buell | Chief Executive Officer | Sell | 6,938 | $10.56 | $73K | Form 4 | |
| Jennifer Buell | Chief Executive Officer | Option exercise | 23,191 | Form 4 | |||
| Ulf Wiinberg | Director | Award | 1,279 | $10.95 | $14K | Form 4 | |
| John Bradley Holcomb | Director | Award | 1,233 | $10.95 | $14K | Form 4 | |
| Peter Behner | Director | Award | 1,485 | $10.95 | $16K | Form 4 | |
| Barbara Ryan | Director | Award | 1,622 | $10.95 | $18K | Form 4 | |
| Brian Corvese | Director | Award | 1,633 | $10.95 | $18K | Form 4 |
Buy and Sell are open-market purchases and sales (transaction codes P and S), the trades investors watch. Awards, option exercises, tax withholding and gifts are reported too but are not market trades.